56 results
Keyword Effentora Remove keyword
-
List item
Withdrawn application: Effentora
fentanyl, date of withdrawal: 11/07/2013, Post-authorisation, Last updated: 29/08/2013Effentora: Withdrawn application … marketing authorisation for Effentora (fentanyl) On 11 July … for a new indication for Effentora, to extend the treatment … -
List item
Human medicine European public assessment report (EPAR): Effentora
fentanyl, Pain; Cancer
Date of authorisation: 04/04/2008, Revision: 28, Authorised, Last updated: 11/11/2022Effentora Pain Cancer … assessment report (EPAR) for Effentora. It explains how the The committee … the conditions of use for Effentora. What is Effentora? Effentora is a medicine that contains … -
List item
News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 22-25 July 2013
CHMP, Last updated: 26/07/2013Effentora … -
List item
Human medicine European public assessment report (EPAR): PecFent
fentanyl, Pain; Cancer
Date of authorisation: 31/08/2010, Revision: 23, Authorised, Last updated: 08/11/2022While the reference medicines Effentora (buccal tablets) and Actiq … While the reference medicines Effentora (buccal tablets) and Actiq … -
List item
Press release: Meeting highlights from the Committee for Medicinal Products for Human Use,21-24 January 2008
CHMP, Last updated: 24/01/2008Effentora … following medicines: • Effentora (fentanyl citrate), from … -
List item
Human medicine European public assessment report (EPAR): Instanyl
Fentanyl citrate, Pain; Cancer
Date of authorisation: 20/07/2009, Revision: 35, Authorised, Last updated: 17/01/2023Withdrawal syndrome: For Effentora/Actiq there have been 54 cases … Pecfent and Breakyl. For Effentora/Actiq there have been 65 reports … Insomnia is already listed for Effentora, Instanyl, Breakyl and Abstral … -
List item
Press release: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP), 21-24 June 2010
CHMP, Last updated: 25/06/2010medicines Actiq lozenges and Effentora buccal tablets are the reference … medicines Actiq lozenges and Effentora buccal tablets are the … -
List item
Referral: Rapinyl
fentanyl citrate, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 26/06/2008, EC decision date: 11/09/2008, Last updated: 25/09/2009 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 4-7 July 2022
European Medicines Agency, Amsterdam, the Netherlands, from 04/07/2022 to 07/07/2022, Last updated: 31/03/2023 -
List item
PRAC: Agendas, minutes and highlights (updated)
Last updated: 21/09/2023 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 7-10 March 2022
European Medicines Agency, Amsterdam, the Netherlands, from 07/03/2022 to 10/03/2022, Last updated: 22/11/2022 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 25-28 October 2021
European Medicines Agency, Amsterdam, the Netherlands, from 25/10/2021 to 28/10/2021, Last updated: 02/08/2022 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 5-8 July 2021
European Medicines Agency, Amsterdam, the Netherlands, from 05/07/2021 to 08/07/2021, Last updated: 10/05/2022 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 26-29 September 2022
European Medicines Agency, Amsterdam, the Netherlands, from 26/09/2022 to 29/09/2022, Last updated: 04/07/2022 -
List item
Committee for Medicinal Products for Human Use (CHMP): 10-13 October 2022
European Medicines Agency, Amsterdam, the Netherlands, from 10/10/2022 to 13/10/2022, Last updated: 23/11/2022 -
List item
Committee for Medicinal Products for Human Use (CHMP): 21-24 March 2022
European Medicines Agency, Amsterdam, the Netherlands, from 21/03/2022 to 24/03/2022, Last updated: 12/08/2022 -
List item
Committee for Medicinal Products for Human Use (CHMP): 11-14 October 2021
European Medicines Agency, Amsterdam, the Netherlands, from 11/10/2021 to 14/10/2021, Last updated: 20/01/2022 -
List item
CHMP: Agendas, minutes and highlights (updated)
Last updated: 11/09/2023 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 2-5 December 2013
European Medicines Agency, London, UK, from 02/12/2013 to 05/12/2013, Last updated: 02/07/2012 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 11-14 January 2021
Virtual meeting, from 11/01/2021 to 14/01/2021, Last updated: 27/02/2018 -
List item
Committee for Medicinal Products for Human Use (CHMP): 24-27 January 2022
European Medicines Agency, Amsterdam, the Netherlands, from 24/01/2022 to 27/01/2022, Last updated: 16/03/2022 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 1-4 December 2014
European Medicines Agency, London, UK, from 01/12/2014 to 04/12/2014, Last updated: 13/08/2013 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 5-8 February 2018
European Medicines Agency, London, UK, from 05/02/2018 to 08/02/2018, Last updated: 13/03/2014 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 6-9 July 2015
European Medicines Agency, London, UK, from 06/07/2015 to 09/07/2015, Last updated: 13/03/2014 -
List item
Committee for Medicinal Products for Human Use (CHMP): 16-19 August 2021
Written procedure, from 16/08/2021 to 19/08/2021, Last updated: 04/11/2019